| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040582141 |
| P356 | DOI | 10.2165/00002018-199615040-00004 |
| P698 | PubMed publication ID | 8905251 |
| P2093 | author name string | L Karalliedde | |
| S Feldman | |||
| P2860 | cites work | Laudanosine (a metabolite of atracurium) increases the minimum alveolar concentration of halothane in rabbits | Q28284935 |
| Anti-acetylcholine receptor antibodies in D-penicillamine-associated myasthenia gravis | Q28318292 | ||
| Prolonged Apnea Following Trimethaphan and Succinylcholine | Q28322258 | ||
| Penicillamine-induced myasthenia gravis associated with antibodies to acetylcholine receptor | Q28330085 | ||
| Respiratory paralysis during treatment of hypertension with trimethaphan camsylate | Q28333619 | ||
| Low Serum Pseudocholinesterase Levels Complicating Treatment with Phenelzine | Q28365503 | ||
| The influence of 10 mg and 20 mg of bambuterol on the duration of succinylcholine-induced neuromuscular blockade | Q34636439 | ||
| The influence of bambuterol (carbamylated terbutaline) on the duration of action of succinylcholine-induced paralysis in humans | Q34684955 | ||
| Neuromuscular inhibition of new aminoglycoside antibiotics | Q34693065 | ||
| Effects of several inhalation anaesthetics on the kinetics of postsynaptic conductance changes in mouse diaphragm | Q35176132 | ||
| Modification of sodium and potassium channel gating kinetics by ether and halothane | Q36408515 | ||
| Clinical Use of Magnesium Infusions in Anesthesia | Q36755396 | ||
| Drug therapy: Disorders of neuromuscular transmission caused by drugs | Q37981337 | ||
| The neuromuscular junction: recent developments | Q38150428 | ||
| Neuromuscular blocking drug pharmacodynamics after chronic exposure to H2- antagonists. | Q38575305 | ||
| Drug blockade of open end-plate channels | Q39118447 | ||
| Influence of diazepam on the effect of neuromuscular blocking agents | Q39176364 | ||
| Decrease in Dose Requireement of d-Tubocurarine by Volatile Anesthetics | Q39272697 | ||
| Lithium and neuromuscular transmission | Q53936252 | ||
| Resistance to decamethonium neuromuscular block after prior administration of vecuronium. | Q54237538 | ||
| The effect of calcium, neostigmine and 4-aminopyridine upon respiratory arrest and depression of cardiovascular functions after aminoglycosidic antibiotics. | Q54522565 | ||
| Pre- and postjunctional blocking effects of aminoglycoside, polymyxin, tetracycline and lincosamide antibiotics | Q67242495 | ||
| Acute respiratory failure following intravenous verapamil in Duchenne's muscular dystrophy | Q67271824 | ||
| Betamethasone-induced resistance to neuromuscular blockade: a comparison of atracurium and vecuronium in vitro | Q67515647 | ||
| Antibiotics and muscle relaxants. A dangerous combination | Q68482562 | ||
| Neuromuscular blocking activity of gentamicin in cats and mice | Q68601659 | ||
| Anticholinesterase activity of and possible ion-channel block by cimetidine, ranitidine and oxmetidine in the toad isolated rectus abdominis muscle | Q68954732 | ||
| Interactions between calcium entry blockers and vecuronium bromide in anaesthetized cats | Q69865973 | ||
| Serum protein and cholinesterase changes in association with contraceptive pills | Q70069399 | ||
| Comparative effects of clindamycin and lincomycin on end-plate currents and quantal content at the neuromuscular junction | Q70170704 | ||
| Neuromuscular blocking action of verapamil in cats | Q70236907 | ||
| Cumulation of neomycin and its residual potentiation of tubocurarine in the cat | Q70819875 | ||
| Effects of primidone, phenobarbital and phenylethylmalonamide in the stimulated frog neuromuscular junction | Q71001126 | ||
| [Etomidate and suxamethonium. The duration of relaxation and pseudocholinesterase activity. A clinical experimental study (author's transl)] | Q71203727 | ||
| Tacrine may prolong the effect of succinylcholine | Q72113922 | ||
| Potentiation and antagonism of vecuronium by decamethonium | Q72213300 | ||
| Glucocorticoid modification of the responsiveness of a fast (type 2) neuromuscular system to edrophonium and d-tubocurarine | Q72862081 | ||
| Comparison of the effects of trimethadione and its primary metabolite dimethadione on neuromuscular function and the effects of altered pH on the actions of dimethadione | Q72933144 | ||
| The nature of the neuromuscular block produced by magnesium | Q73536420 | ||
| The pharmacology of Flaxedil, with observations on certain analogs | Q75930580 | ||
| Effect of enflurane and fentanyl on the clinical characteristics of long-term succinylcholine infusion | Q51864219 | ||
| The mechanism and site of action of ketamine on skeletal muscle. | Q51864673 | ||
| Effects of local anaesthetics on the relationship between charge movements and contractile thresholds in frog skeletal muscle. | Q51865118 | ||
| Controlled succinylcholine infusion in a patient receiving echothiophate eye drops | Q51865926 | ||
| Effect of diazepam on pancuronium-induced neuromuscular blockade maintained by a feedback system | Q51866372 | ||
| Effects of diazepam on evoked electrospinogram and evoked electromyogram in man. | Q51868359 | ||
| Characteristics of succinylcholine-produced phase II neuromuscular block during enflurane, halothane, and fentanyl anesthesia. | Q51868362 | ||
| The effects of local anaesthetics on the isometric contraction of the isolated hemidiaphragm of the rat | Q51868609 | ||
| Influence of suxamethonium on the potency of ORG NC 45 in anaesthetized patients | Q51868919 | ||
| Prolonged neuromuscular blockade following trimetaphan infusion. A case report and in vitro study of cholinesterase inhibition. | Q51871691 | ||
| Neuromuscular drug interactions of clinical importance. | Q51874488 | ||
| Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine. | Q51875100 | ||
| Time-dependent increase in sensitivity to d-tubocurarine during enflurane anesthesia in man. | Q51876057 | ||
| Furosemide facilitates recovery of evoked twitch response after pancuronium. | Q51878557 | ||
| Influence of Halothane and Enflurane on the Neuromuscular Effects of ORG NC 45 in Man | Q52700675 | ||
| The comparative influence of gamma-hydroxy butyric acid, althesin and etomidate on the neuromuscular blocking potency of pancuronium in man | Q52700779 | ||
| Postsynaptic effect of i.v. anaesthetic agents at the neuromuscular junction. | Q52708778 | ||
| Lithium carbonate and neuromuscular blocking agents | Q52710246 | ||
| Myasthenia gravis unmasked by antiarrhythmic agents | Q52713663 | ||
| Influence of induced hypermagnesemia and hypocalcemia on neuromuscular blocking property of oxytetracycline in the horse | Q52716779 | ||
| Ketamine: myoneural activity and interaction with neuromuscular blocking agents. | Q52730853 | ||
| Cyclophosphamide, Cholinesterase and Anaesthesia* | Q52733655 | ||
| Prolonged curarization associated with propranolol | Q52735028 | ||
| Comparative Neuromuscular Effects of Forane and Halothane Alone and in Combination with d-Tubocurarine in Man | Q52737812 | ||
| The Interaction of d-Tubocurarine with Antiarrhythmic Drugs | Q52740837 | ||
| The effect of inhalation anesthetics on repetitive activity generated at motor nerve endings. | Q52757399 | ||
| The Changing Pattern of Neuromuscular Blockade Caused by Succinylcholine in Man | Q52757883 | ||
| ANAESTHESIA FOR ATRIAL DEFIBRILLATION: EFFECT OF QUINIDINE ON MUSCULAR RELAXATION | Q52764935 | ||
| Trimetaphan; its effect on the pseudo-cholinesterase level of man. | Q52774130 | ||
| Modification of curarization after acute administration of 2 antiepileptic drugs | Q39306951 | ||
| Antibiotic-induced paralysis | Q39866296 | ||
| Antibiotic blockade of neuromuscular function | Q39885910 | ||
| Effect of Diazepam at the neuromuscular junction. A clinical study | Q39903982 | ||
| Comparison of the Effects of General Anesthetics on the End-plate of Skeletal Muscle | Q39960477 | ||
| Evidence for a prejunctional role of cyclic nucleotides in neuromuscular transmission | Q40035233 | ||
| The site of the neuromuscular block produced by polymyxin B and rolitetracycline | Q40056848 | ||
| Characterization of the neuromuscular block produced by clindamycin and lincomycin | Q40056854 | ||
| Neuromuscular block by antibiotics: polymyxin B. | Q40076790 | ||
| Preliminary review of the interactions of ORG NC 45 with anaesthetics and antibiotics in animals | Q40083100 | ||
| Clinical pharmacology of vecuronium and atracurium | Q40095393 | ||
| Interaction of Pancuronium and Corticosteroids | Q40103616 | ||
| Presynaptic origin of penicillin afterdischarges at mammalian nerve terminals | Q40116669 | ||
| Review Article Calmodulin and its roles in skeletal muscle function | Q40136007 | ||
| Antibiotic-induced Paralysis of the Mouse Phrenic Nerve–Hemidiaphragm Preparation, and Reversibility by Calcium and by Neostigmine | Q40156387 | ||
| The effect of prednisolone on neuromuscular transmission in the rat diaphragm | Q40244728 | ||
| Neuromuscular blocking property of minocycline in the rabbit | Q40263290 | ||
| Competitive nonspecific binding does not explain the potentiating effects of muscle relaxant combinations. | Q41603711 | ||
| Effects of glucocorticoids on acetylcholine release at the neuromuscular junction [proceedings] | Q42631624 | ||
| Ca2+ uptake and Ca2+ release by skeletal muscle sarcoplasmic reticulum: differing sensitivity to inhalational anesthetics. | Q42654854 | ||
| Pancuronium Reduces Halothane Requirement in Man | Q43486182 | ||
| Partial recovery from pancuronium neuromuscular blockade following hydrocortisone administration | Q43871050 | ||
| Acute versus chronic phenytoin therapy and neuromuscular blockade | Q44748375 | ||
| Quantitative examination of the interaction of competitive neuromuscular blocking agents on the indirectly elicited muscle twitch. | Q46300052 | ||
| Intubation under induction doses of propofol | Q47590636 | ||
| Effect of penicillin on an excitatory synapse | Q48424455 | ||
| Effect of lithium on acetylcholine release and synthesis | Q48744004 | ||
| 1 x ED90 dose of rocuronium bromide: tracheal intubation conditions and time-course of action. | Q51594910 | ||
| Phenytoin-induced resistance to vecuronium. | Q51668687 | ||
| Effect of H2-receptor antagonist pretreatment on vecuronium- and atracurium-induced neuromuscular block. | Q51711763 | ||
| The effect of bambuterol on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase. | Q51725999 | ||
| Dose-dependent effect of metoclopramide on cholinesterases and suxamethonium metabolism. | Q51729434 | ||
| The effect of H2 antagonists on duration of action of suxamethonium in the parturient. | Q51751866 | ||
| Prolongation of succinylcholine block by metoclopramide. | Q51752887 | ||
| Neuromuscular transmission studies in preeclamptic women receiving magnesium sulfate. | Q51779172 | ||
| The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium. | Q51787771 | ||
| Antiestrogenic drugs and atracurium--a possible interaction? | Q51803725 | ||
| Neuromuscular effects of atracurium during halothane-nitrous oxide and enflurane-nitrous oxide anesthesia in humans. | Q51825522 | ||
| Vecuronium infusion dose requirements during fentanyl and halothane anesthesia in humans. | Q51829216 | ||
| Interactions of bupivacaine with ionic channels of the nicotinic receptor. Analysis of single-channel currents | Q51839855 | ||
| Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia | Q51846698 | ||
| Drug interaction? | Q51847918 | ||
| Vecuronium-induced Neuromuscular Blockade during Enflurane, Isoflurane, and Halothane Anesthesia in Humans | Q51848587 | ||
| Clinical and pharmacological actions of a bolus injection of suxamethonium: two phenomena of distinct duration | Q51856155 | ||
| Comparison of thiopental and midazolam on the neuromuscular responses to succinylcholine or pancuronium in humans. | Q51856413 | ||
| Interaction between atracurium and drugs used in anaesthesia. | Q51856727 | ||
| Long-term Succinylcholine Infusion during Isoflurane Anesthesia | Q51857456 | ||
| Possible interaction of pancuronium and tubocurarine with oral neomycin. | Q51860460 | ||
| A reevaluation of calcium-local anesthetic antagonism. | Q51860972 | ||
| Resistance to pancuronium in an asthmatic patient treated with aminophylline and steroids. | Q51861470 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 261-273 | |
| P577 | publication date | 1996-10-01 | |
| P1433 | published in | Drug Safety | Q15724462 |
| P1476 | title | Drug interactions with neuromuscular blockers | |
| P478 | volume | 15 |
| Q38758442 | Drug Interactions with Lithium: An Update |
| Q37725945 | Effect of dexamethasone on the onset time and recovery profiles of cisatracurium |
| Q82616729 | Electric field stimulation of precision-cut lung slices |
| Q90874415 | Evaluating potential refinements to existing Threshold of Toxicological Concern (TTC) values for environmentally-relevant compounds |
| Q42379731 | Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents. |
| Q36017593 | Magnesium deficiency in critical illness |
| Q34443036 | Neurally mediated airway constriction in human and other species: a comparative study using precision-cut lung slices (PCLS). |
| Q33901711 | Organophosphorus poisoning (acute) |
| Q83860730 | Organophosphorus poisoning (acute) |
| Q77481253 | Respiratory failure following oral administration of metoclopramide |
| Q34078487 | Selection of drugs to treat gastro-oesophageal reflux disease: the role of drug interactions |
| Q34552035 | The safety and tolerability of donepezil in patients with Alzheimer's disease |
Search more.